The Australian sharemarket is set to open modestly higher on Thursday as investors continue to assess a busy flow of corporate earnings results.
ASX 200 futures rose 27 points, or 0.3%, to 9,034, pointing to a slightly stronger open.
Overnight, United States benchmarks finished marginally higher after the U.S. Treasury said it would increase buybacks of longer-dated government debt, helping to ease pressure in the bond market.
The Dow Jones Industrial Average, S&P 500 and Nasdaq Composite each gained 0.2%.
Moderna shares soared 177% after the company said its personalised cancer vaccine, developed with Merck & Co, helped reduce melanoma recurrence in a late-stage trial.
Merck shares, a component of the Dow Jones Industrial Average, climbed 12.6%.
The Australian sharemarket fell on Wednesday, tracking weakness on Wall Street as banks came under pressure and technology stocks declined following a regulatory investigation into WiseTech Global.
The S&P/ASX 200 Index fell 16.2 points, or 0.2%, to 9,053.8, with five of the 11 sectors ending lower.
Among companies reporting on Thursday are Australian Finance Group, Auckland International Airport, APA, Brambles, Codan, Charter Hall, Cleanaway Waste Management, Downer EDI, Dexus, Goodman Group, IDP Education, Megaport, Medibank Private, Northern Star Resources, Qube Holdings, Sonic Healthcare, Super Retail Group, Universal Store, Vicinity Centres, Pepper Money and Fortescue.
On the bond markets, the 10-year yield was little changed at 5.015%, while the two-year yield fell 0.7% to 4.6%.
